Ajooni Biotech Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021
For the nine months, sales was INR 535.26 million compared to INR 348.51 million a year ago. Revenue was INR 535.5 million compared to INR 348.63 million a year ago. Net income was INR 10.93 million compared to INR 4.02 million a year ago. Basic earnings per share from continuing operations was INR 0.218 compared to INR 0.09 a year ago. Diluted earnings per share from continuing operations was INR 0.218 compared to INR 0.09 a year ago.